MedPath

Effectiveness of ranitidine in weight gain caused by olanzapine in patients with schizophrenia

Not Applicable
Completed
Conditions
Health Condition 1: null- Schizophrenia
Registration Number
CTRI/2014/07/004740
Lead Sponsor
Central Institute of Psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
75
Inclusion Criteria

1. Subjects satisfying the ICD 10 criteria for schizophrenia admitted in institute as their first episode.

2. Drug free patients for minimum 4weeks on oral antipsychotics and 8 weeks on depot preparation.

3. Those giving written informed consent for study

Exclusion Criteria

1. Any other major comorbid psychiatric diagnosis and substance dependence excluding nicotine and caffeine.

2. Presence of significant medical or neurological illness.

3. BMI > 30kg/m2

4. Not ready for consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath